Stocks to Watch: HCLTech, Zydus Lifesciences, KNR Constructions, ION Exchange and more

5 hours ago

HCLTech expands partnership with Aurobay Technologies; Can Fin Homes approves interim dividend; SBI signs credit line with KfW; updates from Zydus, RBL Bank. Here are few stocks to watch ahead of Tuesday's trading session.

By Megha Rani  December 15, 2025, 11:20:42 PM IST (Updated)

HCLTech Share Price, HCLTech stock, HCLTech shares, HCLTech Olympus, HCLTech new product innovation centre, HCLTech product innovation centre in Hyderabad, HCLTech Olympus product innovation centre, medtech, tech, technology,

Image count1 / 11

HCL Technologies | HCLTech said it has expanded its digital transformation partnership with Aurobay Technologies to support global growth, managing SAP, Siemens Teamcenter PLM and integration services in Sweden and China.

Image count2 / 11

Can Fin Homes | The financial services provider board approved ₹7 interim dividend per share and re-appointed Suresh Srinivasan Iyer as MD CEO, pending RBI approval. The company has fixed December 19, 2025, as the record date.

Image count3 / 11

State Bank of India | SBI will sign a €150-million line of credit with Germany’s KfW on December 16 to fund climate-friendly energy projects.

Intellect Design

Image count4 / 11

Intellect Design Arena | Intellect Design Arena Inc said it has partnered with 35 Canadian credit unions across eight provinces, covering over $13 billion in assets, to enhance digital capabilities across onboarding, accounts, payments and member services.

Arvind SmartSpaces share price, Arvind SmartSpaces stock, Arvind SmartSpaces shares, Arvind SmartSpaces, Arvind SmartSpaces new project, Arvind SmartSpaces acquires new project,

Image count5 / 11

BL Kashyap and Sons | The company said it has secured a ₹615.69 crore work order from Sattva CKC for structural and civil works at the Sattva Chennai Knowledge City project, to be executed over 31 months.

Zydus Life share price, Zydus Life stock, Zydus Life shares, Zydus Life, Zydus Life agreement with rk pharma, rk pharma, Zydus Life rk pharma, oncology drug, oncology product, oncology injectable,

Image count6 / 11

Zydus Lifesciences | The company said its US subsidiary Sentynl Therapeutics’ NDA for Menkes disease therapy CUTX-101 has been accepted by the FDA, with a new PDUFA date of January 14, 2026.

Image count7 / 11

KNR Constructions | The company said it has received an income tax demand of ₹72.03 crore for AY 2007-08 and plans to appeal before the Telangana High Court, adding it expects no material impact.

Image count8 / 11

ION Exchange (India) Ltd | The company said it has won contracts worth around ₹205 crore from Rayzon Energy and INOX Solar for ultra-pure water and wastewater treatment systems for solar projects.

RBL Bank share price, RBL Bank stock,RBL Bank shares, RBL Bank block deal, RBL Bank large trade, RBL Bank stake sale, large trade in RBL Bank, RBL Bank M&M, M&M, M&M to sell stake in RBL Bank, mahindra an dmah

Image count9 / 11

RBL Bank | Buvanesh Tharashankar has resigned as Chief Financial Officer (CFO) of RBL Bank, effective December 15, 2025, the company said in a regulatory filing.

Image count10 / 11

Lemon Tree Hotels | The company said it has signed a new property, Lemon Tree Hotel Bandipur in Nepal, to be managed by its subsidiary Carnation Hotels, strengthening its presence in the country.

Image count11 / 11

Arvind SmartSpaces | The company has acquired a new residential high-rise project in Whitefield, Bengaluru, with 4.6 lakh sq ft saleable area and ₹550 crore topline potential.

Read Full Article at Source